GT Biopharma GTBP Price Prediction

The determination to procure GT Biopharma is entirely contingent on your individualistic risk tolerance. As you may discern, GT Biopharma's value has experienced a fall of -11.54% during the preceding 24 hours, and GT Biopharma has incurred a growth of 30.64% over the prior 30-day duration. Consequently, the determination of whether or not to invest in GT Biopharma will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of GT Biopharma may potentially surge to $1.13 by the end of this year. Looking at GT Biopharma's prospects in a more extended five-year timeline, the stock could potentially growth to as much as $1.08. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental GT Biopharma forecast, the price of GT Biopharma will fall by -0.67% over the next week and reach $0.81 by January 22, 2026.

Based on the our new experimental GT Biopharma forecast, the price of GT Biopharma will increase by 4.68% over the next month and reach $0.85 by February 14, 2026.

As per our most recent prediction on GT Biopharma's value in 2026, GTBP is anticipated to fluctuate within the range of $0.80 and $1.13. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected GT Biopharma price forecast fails to consider sudden and extreme price fluctuations.

GT Biopharma's future appears to be on an upward trend, with an maximum price of $1.08 projected after a period of five years. Based on the GT Biopharma forecast for 2031, GT Biopharma's value may potentially reach its highest peak of approximately $1.08, while its lowest peak is anticipated to be around $0.95.

Based on the our new experimental GT Biopharma price prediction simulation, GTBP’s value in 2026 expected to grow by 39.27% to $1.13 if the best happened. The price will be between $1.13 and $0.80 during 2026.

According to our latest experimental simulation for GT Biopharma price prediction, GTBP’s value could rise by 47.27% to $1.19 in 2027, assuming the most favorable conditions. The price is projected to fluctuate between $1.19 and $0.89 throughout the year.

Our new experimental GT Biopharma price prediction model suggests that GTBP’s value in 2028 could increase by 18.44% , reaching $0.96 in the best-case scenario. The price is expected to range between $0.96 and $0.68 during the year.

Based on our experimental forecast model, GT Biopharma's value may experience a 4.83% growth in 2029, potentially reaching $0.85 under optimal conditions. The predicted price range for 2029 lies between $0.85 and $0.69.

Using our new experimental simulation for GT Biopharma price predictions, GTBP’s value in 2030 is expected to rise by 28.1% , reaching $1.04 in the best scenario. The price is forecasted to range between $1.04 and $0.74 over the course of 2030.

Our experimental simulation indicates that GT Biopharma’s price could grow by 33.42% in 2031, potentially hitting $1.08 under ideal conditions. The price will likely fluctuate between $1.08 and $0.95 during the year.

Based on the findings from our latest experimental GT Biopharma price prediction, GTBP could see a 65.05% rise in value, reaching $1.34 if the most positive scenario plays out in 2032. The price is expected to stay within a range of $1.34 and $1.05 throughout the year.

According to our experimental GT Biopharma price prediction, GTBP’s value is anticipated to rise by 120.32% in 2033, with the highest potential price being $1.79. Throughout the year, GTBP’s price could range from $1.79 and $1.34.

The results from our new GT Biopharma price prediction simulation suggest that GTBP may rise by 160.52% in 2034, potentially reaching $2.12 under the best circumstances. The predicted price range for the year is between $2.12 and $1.72.

Based on our experimental forecast for GT Biopharma’s price, GTBP could grow by 238.62% , with the value potentially hitting $2.75 in 2035. The expected price range for the year lies between $2.75 and $1.97.

Our recent GT Biopharma price prediction simulation suggests that GTBP’s value might rise by 390.03% in 2036, possibly reaching $3.98 if conditions are optimal. The expected price range for 2036 is between $3.98 and $2.60.

According to the experimental simulation, GT Biopharma’s value could rise by 552.98% in 2037, with a high of $5.31 under favorable conditions. The price is expected to fall between $5.31 and $3.89 over the course of the year.